BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2013

Apr 12, 2013

SEC Form 4/A — Form 4/A

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2013-01-01

Reporting Person: Stonehouse Jon P (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-01-01	Common Stock	A	31300	—	Acquired	302019	Direct
2013-01-01	Common Stock	A	31300	—	Acquired	333319	Direct

Footnotes

F1: Annual Employee Restricted Stock Award. Will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant. The number of shares on this Form 4/A has been reduced by 1,953 shares to correct an administrative error.

F2: Retention Restricted Stock Award. Will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant. The number of shares on this Form 4/A has been reduced by 1,953 shares to correct an administrative error.